Physician profile
Daniel L Hiser
NPI 1376577973
$2,613.98
in general payments reported to CMS, 2019-2025
41 companies · $36.94 in 2025
The $36.94 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $249 · 2020: $323 · 2021: $405 · 2022: $472 · 2023: $530 · 2024: $597 · 2025: $36.94.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,164.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,163.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $536.83 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Abbvie INC. | $273.49 | 2021-2024 | |
| Janssen Pharmaceuticals, INC | $204.62 | 2020-2024 | Spravato |
| Glaxosmithkline, LLC. | $147.96 | 2020-2025 | Trelegy Ellipta, Arexvy |
| Amgen INC. | $135.70 | 2022-2024 | Evenity, Prolia, Repatha |
| Lilly USA, LLC | $133.41 | 2019-2024 | Mounjaro, Jardiance |
| Pfizer INC. | $114.78 | 2019-2023 | |
| Amarin Pharma, INC. | $87.47 | 2020-2021 | |
| Seqirus USA INC | $81.39 | 2021-2024 | Flucelvax, Fluad, Flucelvax Quadrivalent |
| Gilead Sciences, INC. | $70.33 | 2021-2022 | |
| Hologic Sales and Service, LLC | $56.86 | 2024 | Aptima |
| Biohaven Pharmaceuticals, INC. | $56.79 | 2021 | |
| Exact Sciences Corporation | $53.95 | 2023-2024 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $48.65 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $39.19 | 2024 |
Show all 40 companies
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Hiser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.